| Patents for C07J 13 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17 (764) |
|---|
| 09/20/2000 | EP1036088A1 Method of preparing 16 alpha,17 alpha-dialkylated steroids |
| 09/12/2000 | US6117994 Intermediates for 16β-methyl steroids |
| 09/12/2000 | US6117860 Nasally administering steroid which binds to a specific neuroepithelial receptor for alleviating premenstrual tension and anxiety |
| 07/19/2000 | EP1020191A1 Medicaments for hypolipidemic and hypoglycemic conditions |
| 07/11/2000 | US6086889 Process for the isolation of Z and E gugulsterones from aerial branches of Commiphora wightii (guggul) |
| 07/05/2000 | EP0554436B1 Gaba receptor modulators |
| 06/29/2000 | WO2000037481A1 BRAIN CELL OR NERVE CELL-PROTECTIVE AGENTS COMPRISING GINSENOSIDE Rb¿1? |
| 05/23/2000 | US6066627 Steroids as neurochemical initiators of change in human blood levels of LH |
| 05/02/2000 | US6057439 Epoxysteroids |
| 04/26/2000 | CN1051762C Vitamin D3 analogs, preparation method and use, and medicinal composition containing same |
| 04/25/2000 | US6054446 17-substituted-17-desoxy-1,3,5-estratrienes. |
| 04/04/2000 | US6046185 6,7-oxygenated steroids and uses related thereto |
| 03/28/2000 | US6043236 Especially preferred for the treatment of rheumatoid arthritis (ra) and multiple sclerosis (ms). |
| 03/08/2000 | EP0783513A4 Novel estrenes for inducing hypothalamic effects |
| 01/25/2000 | US6018062 17-difluoromethylene-estratrienes |
| 12/23/1999 | WO1999033859A3 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 11/30/1999 | US5994568 Estrenes for inducing hypothalamic effects |
| 11/30/1999 | US5994333 Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 11/24/1999 | EP0633893B1 17-substituted steroids useful in cancer treatment |
| 11/23/1999 | US5990099 Treating glc1a glaucoma by administering an angiostatic steroid of given formula |
| 11/16/1999 | US5985862 Treating undesired smooth muscle contractions and inflammatory diseases |
| 10/19/1999 | US5969168 Stimulate autonomic activity |
| 10/13/1999 | EP0948521A1 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 10/12/1999 | US5965552 Administering androsta-4,16-dien-3-ol for treating tension, reducing anxiety; administering to the vomeronasal organ of individual |
| 10/05/1999 | US5962443 19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 09/23/1999 | WO1999033859A9 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 08/25/1999 | CN1226837A Steroids as neurochemical stimulators of VNO to alleviate symptoms of PMS and anxiety |
| 08/18/1999 | CN1044702C Ozonide reducing method |
| 08/17/1999 | US5939570 Estrenes for inducing hypothalamic effects |
| 07/20/1999 | US5925774 Estrenes for inducing hypothalamic effects |
| 07/13/1999 | US5922699 Affecting certain consequent behavior and physiology, e.g., the reduction of anxiety |
| 07/08/1999 | WO1999033859A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 07/07/1999 | CN1222159A 6,7-oxygenated steroids and uses related thereto |
| 07/01/1999 | WO1999032127A1 Angiostatic agents and compositions for controlling ocular hypertension |
| 06/30/1999 | CN1220996A Intermediate for preparation of 16 Beta-methyl steroid |
| 06/23/1999 | EP0924219A2 Novel estrenes for inducing hypothalamic effects |
| 06/10/1999 | WO1999028336A1 METHOD OF PREPARING 16α,17α-DIALKYLATED STEROIDS |
| 06/10/1999 | CA2299396A1 Method of preparing 16.alpha.,17.alpha.-dialkylated steroids |
| 06/09/1999 | EP0920442A1 Process for producing eltanolone |
| 05/26/1999 | EP0917534A2 6,7-oxygenated steroids and uses related thereto |
| 05/19/1999 | EP0915905A1 PROCESS FOR PREPARING 16$g(a)-HYDROXY-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
| 05/19/1999 | CN1043426C Pregna-4,9(11), 16-triene-3,20-dione derivs. prepn. method |
| 05/12/1999 | EP0914165A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 05/06/1999 | EP0912185A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
| 05/06/1999 | EP0589034B1 Method for making 3-alpha-hydroxy,3-beta-substituted-pregnanes |
| 04/06/1999 | US5892069 Estrogenic compounds as anti-mitotic agents |
| 03/16/1999 | US5883087 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 02/03/1999 | EP0721461B1 Synthesis of 17-(3-pyridyl) steroids |
| 01/20/1999 | EP0891188A1 Steroids as neurochemical initiators of change in human blood levels of lh or fsh |
| 12/09/1998 | EP0882062A1 Method of preparing 21-alkylated pregna-1,4,16-trien-3,20-diones |
| 12/08/1998 | US5847173 21-nor-vitamin D compounds |
| 09/16/1998 | EP0863914A1 Tetracyclic triterpenes as cholesterol-lowering and anti-atherosclerosis agents |
| 09/16/1998 | EP0624162B1 Novel steroid intermediates and processes for their preparation |
| 09/08/1998 | US5804576 Derivatives of 5-androsten-17-ones and 5-androstan-17-ones |
| 09/02/1998 | EP0783512A4 Novel androstanes for inducing hypothalamic effects |
| 08/26/1998 | CN1191542A Nor-pregnanes for inducing hypothalamic effects |
| 08/18/1998 | US5795982 Intermediates for 16β-methyl steroids |
| 08/11/1998 | US5792757 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function |
| 08/04/1998 | US5789607 Process for the preparation of 1,25-dihydroxy-16-ene-23-yne-cholecalciferol |
| 07/21/1998 | US5783571 Method of altering hypothalamic function by nasal administration of estrene steroids |
| 06/23/1998 | US5770729 Sulfide compound with polar substituents, formation of sulfoxide, mild conditions, safe, nonpolluting |
| 06/17/1998 | EP0847399A1 Novel estrogens |
| 06/02/1998 | US5760256 Reduction; epoxidation; hydrolysis; acylation |
| 05/26/1998 | US5756722 Intermediates for the preparation of Δ4,9(11),17(20) -pregnatriene-3-ones |
| 05/07/1998 | WO1998018813A1 Method of preparing 21-alkylated pregna-1,4,16-trien-3,20-diones |
| 05/07/1998 | CA2238690A1 Method of preparing 21-alkylated pregna-1,4,16-trien-3,20-diones |
| 05/05/1998 | US5747478 Vitamin D3 analogs for the treatment of psoriasis and sebaceous gland diseases |
| 04/28/1998 | US5744462 Administering glucose-6-phosphate dehydrogenase inhibitor |
| 04/09/1998 | WO1998014194A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of anxiety |
| 04/08/1998 | CN1178536A 17 -difluoromethylene-oesteratrienes |
| 03/25/1998 | EP0830369A1 Novel nor-pregnanes for inducing hypothalamic effects |
| 02/26/1998 | WO1998007741A1 Process for producing eltanolone |
| 02/26/1998 | CA2259897A1 Process for producing eltanolone |
| 02/11/1998 | CN1173181A Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function |
| 02/05/1998 | WO1998004577A1 PROCESS FOR PREPARING 16α-HYDROXY-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
| 02/05/1998 | CA2260121A1 Process for preparing 16.alpha.-hydroxy-estra-1,3,5(10)-triene derivatives |
| 02/03/1998 | US5714481 Administering to mammalian host a glucose-6-phsophate dehydrogenase inhibitor, anticarcinogenic, antiobasity, anti-hyperglycemic, antiaging, anticholesterol and anti-autoimmune agent |
| 01/29/1998 | WO1998003207A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/29/1998 | CA2260253A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/22/1998 | WO1998002450A2 6,7-oxygenated steroids and uses related thereto |
| 01/15/1998 | DE19626400A1 1,4-Addition of alkyl to unsaturated carbonyl compound |
| 01/07/1998 | EP0815120A1 17-difluoromethylene-oestratrienes |
| 12/23/1997 | US5700793 An androstane-17-one and ene steroids; hypoglycemic agent, anticholesterol agent; treating autoimmune diseases |
| 12/11/1997 | WO1997046574A1 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function |
| 12/10/1997 | CN1167489A Novel estrenes for inducing hypothalamic effects |
| 12/09/1997 | US5696106 Steroids useful as anti-cancer and anti-obesity agents |
| 12/03/1997 | CN1166836A Novel androstanes with inducing hypothalamic effects |
| 11/06/1997 | WO1997040836A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
| 11/06/1997 | CA2252876A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs |
| 11/05/1997 | CN1036342C Process for preparing 9,11-dehydro steroids and 9-alpha-hydroxy-16,17-dehydro steroids |
| 10/30/1997 | DE19635418C1 Preparation of eltanolone from epi-sarsasapogenin |
| 10/09/1997 | WO1997036596A1 Steroids as neurochemical initiators of change in human blood levels of lh or fsh |
| 09/24/1997 | CN1035947C Preparation process for hydrocortisone and intermediates |
| 09/18/1997 | DE19631541C1 Simple production of oestriol from 1,3,5(10),16-oestratetraene derivative |
| 08/26/1997 | US5661143 Inhibits (de)polymerization of tubulin to form cellular microtubes; anticarcinogenic,-tumor, inflammatory and wound healing agents; immunology; angiogenesis inhibitors |
| 08/12/1997 | US5656621 Steroids useful as anti-cancer and anti-obesity agents |
| 07/31/1997 | WO1997027209A1 New substituted 19-nor-pregnane derivatives |
| 07/23/1997 | EP0785211A1 New substituted 19-nor-pregnane derivatives |
| 07/16/1997 | EP0783513A1 Novel estrenes for inducing hypothalamic effects |
| 07/16/1997 | EP0783512A1 Novel androstanes for inducing hypothalamic effects |